TY - JOUR
T1 - Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice
AU - Avraham, Yosefa
AU - Van Heukelom, Bob
AU - Zolotarev, Olga
AU - Magen, Iddo
AU - Vorobiev, Lia
AU - Zwas, Donna R.
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/5/15
Y1 - 2022/5/15
N2 - Introduction:: Anorexia nervosa is a psycho-socio-biological disease, characterized by self-starvation and distorted perception of body weight. Patients often over-exercise. Insulin is an anabolic hormone that increases food intake and restores body fat and is present in low levels in anorexia nervosa patients: thus may have therapeutic potential in treating anorexia nervosa. Aims:: to explore whether low levels insulin administration may result in recovery of cerebral function and restoration of metabolic disorder providing a treatment option for anorexia nervosa. Methods:: Female Sabra mice maintained on DR of 2.0 hours per day for 32 days, in cages with or without wheel attached to an electronic counter (activity wheel). They were then permitted to eat ad libitum for additional 15 days. On the second week, mice were injected ip with 0.5U/kg long acting Insulin(Lantus) or saline and cognitive function was evaluated. Insulin administered three times a week during days 8-32. Mice euthanized on day 48 and cerebral levels of monoamines, 2-AG and expression of genes associated with metabolic status were evaluated. Results:: Activity wheel mice decreased body weight, 2-AG, dopamine levels and 5-HT1A and increased Camkk2 and SIRT1 gene expression compared to mice without it. Insulin increased body weight, decreased revolutions, enhanced NPY and normalized Camkk2, SIRT-1, BDNF, elevated 2-AG and improved cognition in the wheel group. Conclusion:: low dose insulin administration to animal model of anorexia associated with exercise, led to alterations and normalization in brain metabolic status and improved cognition. Insulin should be further explored as potential novel treatment for anorexia nervosa.
AB - Introduction:: Anorexia nervosa is a psycho-socio-biological disease, characterized by self-starvation and distorted perception of body weight. Patients often over-exercise. Insulin is an anabolic hormone that increases food intake and restores body fat and is present in low levels in anorexia nervosa patients: thus may have therapeutic potential in treating anorexia nervosa. Aims:: to explore whether low levels insulin administration may result in recovery of cerebral function and restoration of metabolic disorder providing a treatment option for anorexia nervosa. Methods:: Female Sabra mice maintained on DR of 2.0 hours per day for 32 days, in cages with or without wheel attached to an electronic counter (activity wheel). They were then permitted to eat ad libitum for additional 15 days. On the second week, mice were injected ip with 0.5U/kg long acting Insulin(Lantus) or saline and cognitive function was evaluated. Insulin administered three times a week during days 8-32. Mice euthanized on day 48 and cerebral levels of monoamines, 2-AG and expression of genes associated with metabolic status were evaluated. Results:: Activity wheel mice decreased body weight, 2-AG, dopamine levels and 5-HT1A and increased Camkk2 and SIRT1 gene expression compared to mice without it. Insulin increased body weight, decreased revolutions, enhanced NPY and normalized Camkk2, SIRT-1, BDNF, elevated 2-AG and improved cognition in the wheel group. Conclusion:: low dose insulin administration to animal model of anorexia associated with exercise, led to alterations and normalization in brain metabolic status and improved cognition. Insulin should be further explored as potential novel treatment for anorexia nervosa.
KW - 2-arachidonoylglycerol (2-AG)
KW - Animal Model(AM)
KW - Anorexia Nervosa(AN)
KW - Exercise
KW - Insulin Lantus
KW - brain-derived neurotrophic factor (BDNF)
UR - https://www.scopus.com/pages/publications/85125226393
U2 - 10.1016/j.physbeh.2022.113738
DO - 10.1016/j.physbeh.2022.113738
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35182554
AN - SCOPUS:85125226393
SN - 0031-9384
VL - 249
JO - Physiology and Behavior
JF - Physiology and Behavior
M1 - 113738
ER -